Skip to content

CoCo in cancer rehabilitation: evaluation of use, satisfaction and clinical effects

CoCo in cancer rehabilitation: evaluation of use, satisfaction and clinical effects - CoCo in oncology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35213
Enrollment
32
Registered
2011-09-06
Start date
2011-09-07
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichameljike en psychosociale gevolgen na (behandeling van) kanker cancer malignant neoplasm

Interventions

The CoCo oncology application is a technology assisted service to improve physial and mental fitness. The application consists of two modules for the patient: (1) activity registration with feedback

Sponsors

Revalidatiecentrum Het Roessingh
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age > 18 years; - finished primary curative treatment for > 3 months (except herceptin, Tamoxifen, etc.); - cancer related symptoms; - sufficient physical capacities to participate in sport activities twice a week; - mild to moderate psychosocial symptoms and fatigue (Symptom Checklist-90

Exclusion criteria

Exclusion criteria: - palliative demand for care; - serious psychopathology; - insufficient understanding of the Dutch language.

Design outcomes

Primary

MeasureTime frame
The implementation of the CoCo oncology application will be evaluated in terms of use (login, number and type of exercises, fims and questionnaires that have been filled in and/or seen, amount of time that have been spent on the program), satisfaction with the technology (UTAUT questionnaire), satisfaction with the treatment (CSQ) and quality of the provision of the services (SERVQUAL questionnaire).

Secondary

MeasureTime frame
The clinical effectiveness will be evaluated in terms of burden of the disease (10-point NRS), quality of life (EORTC-QLQ-C30), phyical functioning (SF-36), fatigue (CIS-20), anxiety (HADS-A) and depression (HADS-D).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)